The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VIOLET: A phase I/II trial evaluation of radioligand treatment in men with metastatic castration-resistant prostate cancer with [161Tb]Tb-PSMA-I&T.
 
James Patrick Buteau
No Relationships to Disclose
 
Louise Kathleen Kostos
Honoraria - Bayer
 
Ramin Alipour
No Relationships to Disclose
 
Price Jackson
No Relationships to Disclose
 
Lachlan McIntosh
No Relationships to Disclose
 
Brittany Emmerson
No Relationships to Disclose
 
Mohammad B Haskali
Patents, Royalties, Other Intellectual Property - Hi hold two active patent applications for discoveries unrelated to this work. One of the patent applications is provisional and the other is a full patent. Both applications are owned by my current and previous institutions. (Inst)
 
Theresa Yeung
No Relationships to Disclose
 
Sophia Xie
No Relationships to Disclose
 
Elizabeth Medhurst
No Relationships to Disclose
 
Rajeev Ravi
No Relationships to Disclose
 
Brian D. Gonzalez
Stock and Other Ownership Interests - Elly Health
Consulting or Advisory Role - KemPharm; Sure Med Compliance
Patents, Royalties, Other Intellectual Property - US Trademark Serial Number 88480263 (virtual reality software)
 
Heidi Fettke
No Relationships to Disclose
 
Nicole Ng
No Relationships to Disclose
 
Maria Docanto
No Relationships to Disclose
 
Patricia Bukczynska
No Relationships to Disclose
 
Benjamin Blyth
No Relationships to Disclose
 
Luc Furic
Employment - CSL Behring (I)
Stock and Other Ownership Interests - CSL Behring (I)
Research Funding - Pimera Pty Ltd, Senhwa Biosciences, Isotopia Molecular Imaging
Patents, Royalties, Other Intellectual Property - Abbvie (I)
 
Arun Azad
Honoraria - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hinova Pharmaceuticals (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono; Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen; Merck Serono; Pfizer; Sanofi; Tolmar
 
Michael S Hofman
Consulting or Advisory Role - Endocyte; Janssen; POINT Biopharma
Speakers' Bureau - Astellas Pharma; AstraZeneca; Janssen; Mundipharma
Research Funding - Advanced Accelerator Applications/Novartis (Inst); Bayer (Inst); Endocyte (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen